|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/36 | (2006.01) |
| A61K 38/36 | (2013.01) | ||
| A61K 38/37 | (2013.01) | ||
| A61K 38/37 | (2006.01) | ||
| A61K 35/14 | (2015.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K 1/00 | (2006.01) | ||
| A61K 47/60 | (2017.08) | ||
| C07K 14/745 | (2006.01) | ||
| A61K 47/54 | (2017.08) | ||
| C07K 14/755 | (2006.01) | ||
| A61K 47/61 | (2017.08) | ||
| C07K 7/08 | (2006.01) | ||
| C07K 14/755 | (2013.01) | ||
| C07K 14/49 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61P 7/04 | (2018.01) | ||
| C07K 14/76 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K 14/59 | (2006.01) | ||
| C07K 14/00 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| C07K 14/79 | (2006.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61K 47/60 | (2017.01) | ||
| A61K 47/61 | (2017.01) | ||
| A61K 47/54 | (2017.01) |
| (11) | Patento numeris | 3033098 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14835927.6 |
| Europos patento paraiškos padavimo data | 2014-08-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/051147 |
| Data | 2014-08-14 |
| (87) | Numeris | WO 2015/023894 |
| Data | 2015-02-19 |
| (30) | Numeris | Data | Šalis |
| 201361866017 P | 2013-08-14 | US |
| (72) |
PETERS, Robert T. , US
KULMAN, John , US
|
| (73) |
Bioverativ Therapeutics Inc. ,
225 Second Avenue, Waltham, MA 02451,
US
|
| (54) | RECOMBINANT FACTOR VIII PROTEINS |
| RECOMBINANT FACTOR VIII PROTEINS |